GGrantIndex
Sort

53,477 grants matching addiction

Rural Comorbidity and HIV consequences of Opioid use Research and Treatment Initiative (Rural cohort)

$733,846
Heidi M. Crane · University Of Washington · U24 · FY2023 · DA

Early Stress and the Neurobiology of Susceptibility and Resilience to Substance Use Disorders

$733,785
Martin H Teicher · Mclean Hospital · R01 · FY2024 · DA

Detecting Crack and Other Cocaine Use With FastPatches

$733,760
Social Sciences Innovations Corporation · R44 · FY2004 · DA

Epigenetic Marks of Cocaine Addiction

$733,621
Deborah C. Mash · University Of Miami School Of Medicine · R01 · FY2014 · DA

Cannabinergic Medications for Methamphetamine Addiction

$733,538
Alexandros Makriyannis · Northeastern University · R37 · FY2014 · DA

Does medical cannabis reduce opioid analgesics in HIV+ and HIV- adults with pain?

$733,464
Julia H. Arnsten · Albert Einstein College Of Medicine · R01 · FY2021 · DA

Determining the Contributions of Four AARDoC Functional Domains to the Etiology of Heavy Drinking and AUD Symptoms: A Prospective, Multimodal Approach

$733,435
Bruce D Bartholow · University Of Iowa · R01 · FY2025 · AA

Identifying Methamphetamine Risk Variants by Extreme Phenotype Exome Sequencing

$733,385
Robert T Malison · Yale University · R01 · FY2016 · DA

Risks for Transitions in Drug use Among Urban Adults

$733,379
William W Eaton · Johns Hopkins University · R01 · FY2010 · DA

Lasting Neurological Effects of Perinatal Opioids

$733,169
Mary Kay Lobo · University Of Maryland Baltimore · R01 · FY2022 · DA

Mechanisms Mediating Cocaine Abuse in Socially Housed Female and Male Monkeys

$733,121
Michael A Nader · Wake Forest University Health Sciences · R01 · FY2022 · DA

Mechanism of Action of a Novel Golgi-Targeted Anti-Cancer Agent

$733,096
Seth J Field · Case Western Reserve University · R01 · FY2021 · CA

Imaging sex differences in smoking-induced dopamine release via novel PET methods

$733,075
Evan D Morris · Yale University · R01 · FY2017 · DA

Brain Temperature, Reward, And Drugs Of Abuse

$733,042
Eugene A Kiyatkin · National Institute On Drug Abuse · Z01 · FY2007 · DA

PET imaging of a4b2 nicotinic receptor upregulation and smoking cessation

$732,915
William N. Green · University Of Chicago · R01 · FY2017 · DA

HIGH FIELD MR RESEARCH IN DRUG ABUSE

$732,855
Mc Lean Hospital (Belmont, Ma) · R01 · FY2005 · DA

Development of Co-Morbid PTSD and Chronic Pain Among Inner-City Women

$732,818
Stevan Hobfoll · Rush University Medical Center · R01 · FY2017 · DA

Smartphone-Based Intervention for Sleep Disturbance in Individuals Recovering from Alcohol Use Disorder

$732,669
Ellen Frank · Health Rhythms, Inc. · R44 · FY2021 · AA

Development of a Human Hydrolase to Treat Cocaine Abuse and Overdose:Rat Models

$732,603
William S Brimijoin · Mayo Clinic Rochester · R01 · FY2009 · DA

USF Center on Co-occurring Disorders, Justice, & Multidisciplinary

$732,526
Roger Hugh Peters · University Of South Florida · P30 · FY2009 · DA

oxycodone addiction: molecular and biochemical consequences

$732,504
Jean Lud Cadet · National Institute On Drug Abuse · ZIA · FY2021 · DA

Expanding the Click City: Tobacco Prevention Program to Include E-cigarettes and Other Novel Tobacco Products

$732,500
Judy A Andrews · Oregon Res Behavioral Intervention Strat · R44 · FY2018 · DA

Morphine and the Neuropathogenesis of SIV in Macaques

$732,432
Shilpa J Buch · University Of Nebraska Medical Center · R01 · FY2010 · DA

Developmental Changes in Neural Processes Underlying Impulsivity and ADHD

$732,375
Julie B Schweitzer · University Of California At Davis · R01 · FY2014 · MH

Mindfulness Influences on Self-Regulation: Mental and Physical Health Implications

$732,354
Eric Loucks · Brown University · UH2 · FY2016 · AT